Andrew Wang

Mr. Wang has more than 27 years of extensive experience in financial service and accounting aspect, include corporate finance and treasury management, corporate accounting, compliance, internal control and corporate budgetary management. Mr. Wang is the Chief Financial Officer of the Company and is responsible for the management of all aspects of the Group’s finance and treasury matters. Prior to joining Frontage in October 2020, Mr. Wang was the Chief Financial Officer of Frontida Biopharm, Inc., a contract development and manufacturing organization in the United States of America. Previously, he was the Chief Financial Officer and the Director of the Board of Sky Solar Holdings, Ltd. a NASDAQ listed company. Before that, he served as finance director or controller in different multinational companies, mainly in the Asia Pacific area.

Mr. Wang is a professional accountant, having been a member of the China Institute of Certified Public Accountant since August 1995. Mr. Wang was awarded an Executive Master of Business Administration by Washington University in St. Louis in December 2004. In July 1993, he was awarded a Bachelor’s degree in Accounting by University of Shanghai for Science and Technology.